2014
DOI: 10.1371/journal.pone.0086447
|View full text |Cite
|
Sign up to set email alerts
|

AT1 Receptor Blockade Attenuates Insulin Resistance and Myocardial Remodeling in Rats with Diet-Induced Obesity

Abstract: BackgroundAlthough obesity has been associated with metabolic and cardiac disturbances, the carrier mechanisms for these responses are poorly understood. This study analyzed whether angiotensin II blockade attenuates metabolic and cardiovascular disorders in rats with diet-induced obesity.Material and MethodsWistar-Kyoto (n = 40) rats were subjected to control (C; 3.2 kcal/g) and hypercaloric diets (OB; 4.6 kcal/g) for 30 weeks. Subsequently, rats were distributed to four groups: C, CL, OB, and OBL. L groups r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
44
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 46 publications
(49 citation statements)
references
References 51 publications
4
44
1
Order By: Relevance
“…Moreover, studies have shown that angiotensin II can decrease insulin sensitivity and induce insulin resistance [35]. After binding to the AT1 receptor, the AT1 receptor autoantibody exerts angiotensin II-like effects involving insulin resistance [36].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, studies have shown that angiotensin II can decrease insulin sensitivity and induce insulin resistance [35]. After binding to the AT1 receptor, the AT1 receptor autoantibody exerts angiotensin II-like effects involving insulin resistance [36].…”
Section: Discussionmentioning
confidence: 99%
“…Echocardiogram was performed before and after NAC treatment (Vivid S6, General Electric Medical Systems, Tirat Carmel, Israel) using a 5 to 11.5 MHz electronic transducer, according to a previously described method [26,27,28,29]. …”
Section: Methodsmentioning
confidence: 99%
“…Pathological cardiac hypertrophy and dysfunction associated with metabolic disorders have been reported in obesity [4,5,6]. The obese Zucker rat (OZR), a genetic model of morbid obesity, presents many of the same cardiovascular deficits noted in obese humans including myocardial hypertrophy [5,7], cardiac microvascular rarefaction [8], and exercise intolerance [5,9].…”
Section: Introductionmentioning
confidence: 99%